(Q43504074)

24 November 2017

title

Design, synthesis, and biological activity of a cyclic peptide: an inhibitor of HIV-1 tat-TAR interactions in human cells (English)

1 reference

24 November 2017

Tamilarasu N

1

1 reference

24 November 2017

Huq I

series ordinal

2

1 reference

24 November 2017

Rana TM

series ordinal

3

1 reference

24 November 2017

language of work or name

English

0 references

publication date

1 May 2000

1 reference

24 November 2017

number of pages

4

1 reference

Bioorganic & Medicinal Chemistry Letters

inferred from page(s)

published in

1 reference

24 November 2017

volume

10

1 reference

24 November 2017

issue

9

1 reference

24 November 2017

page(s)

971-974

1 reference

Design of a G.C-specific DNA minor groove-binding peptide.

24 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2800%2900140-2

7 January 2021

Recognition of DNA by designed ligands at subnanomolar concentrations

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2800%2900140-2

7 January 2021

Regulation of gene expression by small molecules

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2800%2900140-2

7 January 2021

Disruption of IRS-2 causes type 2 diabetes in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2800%2900140-2

7 January 2021

Control of RNA initiation and elongation at the HIV-1 promoter

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2800%2900140-2

7 January 2021

Inhibition of gene expression in human cells through small molecule-RNA interactions

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2800%2900140-2

7 January 2021

Production of cyclic peptides and proteins in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2800%2900140-2

7 January 2021

Nonphosphorylated peptide ligands for the Grb2 Src homology 2 domain

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2800%2900140-2

7 January 2021

Phenylpropionic acid-based cyclic prodrugs of opioid peptides that exhibit metabolic stability to peptidases and excellent cellular permeation

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2800%2900140-2

7 January 2021

Simultaneous multiple synthesis and selective conjugation of cyclized peptides derived from a surface loop of a meningococcal class 1 outer membrane protein

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2800%2900140-2

7 January 2021

Synthesis of a template-associated peptide designed as a transmembrane ion channel former

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2800%2900140-2

7 January 2021

Synthesis and kinetics of cyclization of MHC class II-derived cyclic peptide vaccine for diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2800%2900140-2

7 January 2021

Biological and structural properties of cyclic peptides derived from the alpha-amylase inhibitor tendamistat.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2800%2900140-2

7 January 2021

Miniaturized proteins: the backbone cyclic proteinomimetic approach

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2800%2900140-2

7 January 2021

Circular β-lactamase: stability enhancement by cyclizing the backbone

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2800%2900140-2

7 January 2021

Synthesis and activity profiles of novel cyclic opioid peptide monomers and dimers

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2800%2900140-2

7 January 2021

Synthesis and binding affinities of cyclic and related linear analogues of CCK8 selective for central receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2800%2900140-2

7 January 2021

Potent and prolonged acting cyclic lactam analogues of alpha-melanotropin: design based on molecular dynamics

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2800%2900140-2

7 January 2021

Conformation-based design of two cyclic physalaemin analogues

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2800%2900140-2

7 January 2021

Investigation of conformational specificity at GPIIb/IIIa: evaluation of conformationally constrained RGD peptides

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2800%2900140-2

7 January 2021

Synthesis and conformational analysis of cyclic pentapeptide endothelin antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2800%2900140-2

7 January 2021

Solution structure of Compstatin, a potent complement inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2800%2900140-2

7 January 2021

Solid-phase synthesis of cyclic homodetic peptides

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2800%2900140-2

7 January 2021

Synthesis of biologically active cyclic peptides

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2800%2900140-2

7 January 2021

A quantitative bioassay for HIV-1 based on trans-activation.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2800%2900140-2

7 January 2021

Cellular uptake of the tat protein from human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2800%2900140-2

7 January 2021

10.1016/S0960-894X(00)00140-2

Identifiers

DOI

1 reference

24 November 2017

1 reference